Documents
Briefs, oral arguments, agency decisions and the Federal Register.
13 results
1.43s
Federal Register · Notice · Jul 18, 2008
; Notice of 60-Day Public Comment Period AGENCY: Executive Office of the President, Office of National Drug Control Policy. … ACTION: Notice of 60-day public comment period.
73 FR 41382Executive Office of the PresidentOffice of National Drug Control PolicyFederal Register · Notice · Jan 7, 2005
Period AGENCY: Executive Office of the President, Office of National Drug Control Policy. … ACTION: Notice of 60-day public comment period.
70 FR 1442Executive Office of the PresidentOffice of National Drug Control PolicyFederal Register · Notice · Sep 28, 2022
The Federal Register notice that solicited public comment on the information collection for a period of 60 days was published June 23, 2022. … The purpose of this notice is to allow for an additional 30 days of public comments. OMB may act on ONDCP's ICR only after the 30-day comment period for this Notice has closed.
87 FR 58824Executive Office of the PresidentOffice of National Drug Control PolicyPaperwork Reduction Act; Proposed Collection; Comment Request
Federal Register · Notice · Jul 18, 2019
ACTION: Notice of submission to OMB and 30-day public comment period. … The Federal Register notice that solicited public comment on the information collection for a period of 60 days was published May 9, 2019, 84 FR 20357. A.
84 FR 34391Executive Office of the PresidentOffice of National Drug Control PolicyFederal Register · Notice · Jun 21, 2002
ACTION: Proposed guidelines and corrections to comment request. SUMMARY: This notice requests comment on proposed guidelines. … They were accompanied by a request for comments, however, the email address listed was incorrect. This notice has the correct email address and an extended comment period to July 15, 2002.
67 FR 42255Executive Office of the PresidentCouncil on Environmental QualityFederal Register · Notice · Jun 19, 2003
Office of the President, Office of National Drug Control Policy is requesting OMB review and approval of this information collection thirty two days from the date of publication, with an 180-day approval period … Zobeck, Ph.D., Acting Deputy Associate Director for Planning and Budget, Washington, DC 20503, Fax Number: (202) 395-5571.
68 FR 36858Executive Office of the PresidentOffice of National Drug Control PolicyPrivacy Act of 1974; System of Records
Federal Register · Notice · Jan 18, 2024
to comment, described below. … Therefore, please submit any comments by February 20, 2024. ADDRESSES: Address all comments in writing within 30 days to Anthony Jones, Deputy General Counsel.
89 FR 3433Executive Office of the PresidentOffice of National Drug Control PolicyHigh Intensity Drug Trafficking Areas; Petitions for Designation
Federal Register · Notice · Aug 16, 2007
A 60-day public comment period was established. The June 4 Notice stated that any written comments must be received by ONDCP via electronic mail or facsimile on or before August 3, 2007. … SUPPLEMENTARY INFORMATION: The Anti-Drug Abuse Act of 1988, the ONDCP Reauthorization Act of 1998, and the ONDCP Reauthorization Act of 2006 authorize the Director of the Office of National Drug Control
72 FR 46099Executive Office of the PresidentOffice of National Drug Control PolicyFederal Register · Notice · Mar 16, 2004
Comments on these systems of records should be submitted in writing before April 26, 2004. … Roberts, Acting General Counsel.
69 FR 12326Executive Office of the PresidentOffice of AdministrationOffice of National Drug Control Policy
Federal Register · Notice · Mar 5, 1996
In addition, various sub-committees meet periodically throughout the year. … FOR FURTHER INFORMATION CONTACT: Comments and questions regarding the Drug Control Research, Data, and Evaluation Committee (DCRDEC) should be directed to Mr. Edward H.
61 FR 8622Executive Office of the PresidentMemorandum for the Heads of Executive Departments and Agencies
Federal Register · Notice · Jan 26, 2009
Subject to any exceptions the Director or Acting Director of the Office of Management and Budget (the “OMB Director”) allows for emergency situations or other urgent circumstances relating to health, safety … Where such an extension is made for this purpose, you should immediately reopen the notice-and-comment period for 30 days to allow interested parties to provide comments about issues of law and policy
74 FR 4435Executive Office of the PresidentThe White House OfficeFederal Register · Notice · Mar 3, 2022
If you have witnessed or experienced any harmful acts that may undermine scientific integrity and you would like to report these allegations, please contact the scientific integrity office or the Office … All Federal agencies—not just those that fund and conduct scientific research—need to develop, implement, and periodically review and update scientific integrity policies and that agencies need to apply
87 FR 12165Executive Office of the PresidentFederal Register · Notice · Feb 19, 1998
One commentator questioned the relationship of the Circular to the Federal Advisory Committee Act (FACA). … Other commentators proposed extending the review period to ten years (in order to mirror the review cycle of the Regulatory Flexibility Act) or to eliminate the review entirely because it was burdensome
63 FR 8546Justice DepartmentExecutive Office of the President
Ask Donna what matters in the record.
She can read the source against your case and show you exactly where the answer came from.